Full Press Release Details
latest dupixent dupilumab and itepekimab data at ers highlight scientific innovation and leadership in respiratory diseases.
REGN
latest dupixent dupilumab and itepekimab data at ers highlight scientific innovation and leadership in respiratory diseases
Key Takeaway: latest dupixent dupilumab and itepekimab data at ers highlight scientific innovation and leadership in respiratory diseases